氨甲环酸和ε-氨基己酸能否充分替代抑肽酶？ - Suppr

Suppr

超能文献

Are tranexamic acid and ε-aminocaproic acid adequate substitutes for aprotinin?

作者信息

Tempe Deepak K, Hasija Suruchi

出版信息

Ann Card Anaesth. 2012 Jan-Mar;15(1):4-5. doi: 10.4103/0971-9784.91465.

DOI:10.4103/0971-9784.91465

PMID:22234014

Abstract

摘要

相似文献

Are tranexamic acid and ε-aminocaproic acid adequate substitutes for aprotinin?

Ann Card Anaesth. 2012 Jan-Mar;15(1):4-5. doi: 10.4103/0971-9784.91465.

Seizures after adult cardiac surgery.

J Cardiothorac Vasc Anesth. 2011 Aug;25(4):e25-6. doi: 10.1053/j.jvca.2011.02.020. Epub 2011 Apr 22.

Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid.

J Cardiothorac Vasc Anesth. 2011 Feb;25(1):20-5. doi: 10.1053/j.jvca.2010.10.007.

Con: Antifibrinolytics Should Not Be Used Routinely in Low-Risk Cardiac Surgery.

J Cardiothorac Vasc Anesth. 2016 Jan;30(1):248-51. doi: 10.1053/j.jvca.2015.08.013. Epub 2015 Aug 20.

Risk factors associated with postoperative seizures in patients undergoing cardiac surgery who received tranexamic acid: a case-control study.

Ann Card Anaesth. 2012 Jan-Mar;15(1):6-12. doi: 10.4103/0971-9784.91467.

eComment: A comparison of the safety of aprotinin and tranexamic acid in cardiac surgery.

Interact Cardiovasc Thorac Surg. 2009 Jul;9(1):101. doi: 10.1510/icvts.2008.198325A.

"Seizing" the opportunity to understand antifibrinolytic drugs.

Can J Anaesth. 2012 Jan;59(1):1-5. doi: 10.1007/s12630-011-9621-4. Epub 2011 Nov 4.

The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients.

Anesth Analg. 2008 Dec;107(6):1783-90. doi: 10.1213/ane.0b013e318184bc20.

Comparison of tranexamic acid with aprotinin in pediatric cardiac surgery.

Ann Card Anaesth. 2015 Jan-Mar;18(1):27-8. doi: 10.4103/0971-9784.148317.

ε-Aminocaproic acid and clinical value in cardiac anesthesia.

J Cardiothorac Vasc Anesth. 2011 Feb;25(1):16-9. doi: 10.1053/j.jvca.2010.07.024. Epub 2010 Sep 25.

引用本文的文献

Aprotinin-Drug against Respiratory Diseases.

Int J Mol Sci. 2023 Jul 6;24(13):11173. doi: 10.3390/ijms241311173.

Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R with C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1.

J Clin Med. 2020 Nov 17;9(11):3684. doi: 10.3390/jcm9113684.

Pharmacological management of perioperative bleeding in cardiac surgery.

Glob Cardiol Sci Pract. 2017 Jun 30;2017(2):12. doi: 10.21542/gcsp.2017.12.

Regulatory decisions pertaining to aprotinin may be putting patients at risk.

CMAJ. 2014 Dec 9;186(18):1379-86. doi: 10.1503/cmaj.131582. Epub 2014 Sep 29.

[Cardiopulmonary bypass in cardiac surgery].

Anaesthesist. 2012 Oct;61(10):846-56. doi: 10.1007/s00101-012-2050-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Are tranexamic acid and ε-aminocaproic acid adequate substitutes for aprotinin?

Ann Card Anaesth. 2012 Jan-Mar;15(1):4-5. doi: 10.4103/0971-9784.91465.

Seizures after adult cardiac surgery.

J Cardiothorac Vasc Anesth. 2011 Aug;25(4):e25-6. doi: 10.1053/j.jvca.2011.02.020. Epub 2011 Apr 22.

Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid.

J Cardiothorac Vasc Anesth. 2011 Feb;25(1):20-5. doi: 10.1053/j.jvca.2010.10.007.

Con: Antifibrinolytics Should Not Be Used Routinely in Low-Risk Cardiac Surgery.

J Cardiothorac Vasc Anesth. 2016 Jan;30(1):248-51. doi: 10.1053/j.jvca.2015.08.013. Epub 2015 Aug 20.

Risk factors associated with postoperative seizures in patients undergoing cardiac surgery who received tranexamic acid: a case-control study.

Ann Card Anaesth. 2012 Jan-Mar;15(1):6-12. doi: 10.4103/0971-9784.91467.

eComment: A comparison of the safety of aprotinin and tranexamic acid in cardiac surgery.

Interact Cardiovasc Thorac Surg. 2009 Jul;9(1):101. doi: 10.1510/icvts.2008.198325A.

"Seizing" the opportunity to understand antifibrinolytic drugs.

Can J Anaesth. 2012 Jan;59(1):1-5. doi: 10.1007/s12630-011-9621-4. Epub 2011 Nov 4.

The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients.

Anesth Analg. 2008 Dec;107(6):1783-90. doi: 10.1213/ane.0b013e318184bc20.

Comparison of tranexamic acid with aprotinin in pediatric cardiac surgery.

Ann Card Anaesth. 2015 Jan-Mar;18(1):27-8. doi: 10.4103/0971-9784.148317.

ε-Aminocaproic acid and clinical value in cardiac anesthesia.

J Cardiothorac Vasc Anesth. 2011 Feb;25(1):16-9. doi: 10.1053/j.jvca.2010.07.024. Epub 2010 Sep 25.

引用本文的文献

Aprotinin-Drug against Respiratory Diseases.

Int J Mol Sci. 2023 Jul 6;24(13):11173. doi: 10.3390/ijms241311173.

Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R with C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1.

J Clin Med. 2020 Nov 17;9(11):3684. doi: 10.3390/jcm9113684.

Pharmacological management of perioperative bleeding in cardiac surgery.

Glob Cardiol Sci Pract. 2017 Jun 30;2017(2):12. doi: 10.21542/gcsp.2017.12.

Regulatory decisions pertaining to aprotinin may be putting patients at risk.

CMAJ. 2014 Dec 9;186(18):1379-86. doi: 10.1503/cmaj.131582. Epub 2014 Sep 29.

[Cardiopulmonary bypass in cardiac surgery].

Anaesthesist. 2012 Oct;61(10):846-56. doi: 10.1007/s00101-012-2050-0.